her nose has been bleeding and all that and the mucous has a smell to it but states her nose running is ongoing and better; congestion; she is not feeling well; diarrhea; the 3rd dose was administered; Sick; face is hurting; nose is running/still blowing mucous from her nose and it was white but now is green; has been having fevers; Dizziness; rash on her right leg; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 70 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 03Dec2021 11:00 (Batch/Lot number: unknown) at the age of 70 years as dose 3 (booster), single for covid-19 immunisation; streptococcus pneumoniae (STREPTOCOCCUS PNEUMONIAE), administered in arm left (Batch/Lot number: unknown) for immunisation. Relevant medical history included: "Chronic obstructive pulmonary disease" (ongoing), notes: diagnosed over 10 years ago; "Asthma" (ongoing), notes: diagnosed over 10 years ago; "high blood pressure" (ongoing), notes: diagnosed over 10 years ago. Concomitant medication(s) included: LOSARTAN POTASSIUM taken for blood pressure measurement. Vaccination history included: Bnt162b2 (First dose, lot number EM9809), administration date: 15Mar2021, when the patient was 69 years old, for COVID-19 Immunization; Bnt162b2 (Second dose, lot number EM9809), administration date: 09Apr2021, when the patient was 69 years old, for COVID-19 Immunization. The following information was reported: IMMUNISATION (non-serious) with onset 03Dec2021 11:00, outcome "unknown", described as "the 3rd dose was administered"; ILLNESS (non-serious) with onset Dec2021, outcome "recovering", described as "Sick"; FACIAL PAIN (non-serious) with onset Dec2021, outcome "recovering", described as "face is hurting"; RHINORRHOEA (non-serious) with onset Dec2021, outcome "recovering", described as "nose is running/still blowing mucous from her nose and it was white but now is green"; PYREXIA (non-serious) with onset Dec2021, outcome "recovering", described as "has been having fevers"; DIZZINESS (non-serious) with onset Dec2021, outcome "recovering", described as "Dizziness"; RASH (non-serious) with onset Dec2021, outcome "recovering", described as "rash on her right leg"; DIARRHOEA (non-serious) with onset 05Jan2022, outcome "unknown", described as "diarrhea"; EPISTAXIS (non-serious), outcome "unknown", described as "her nose has been bleeding and all that and the mucous has a smell to it but states her nose running is ongoing and better"; NASAL CONGESTION (non-serious), outcome "unknown", described as "congestion"; MALAISE (non-serious), outcome "unknown", described as "she is not feeling well". Therapeutic measures were taken as a result of rhinorrhoea, epistaxis, nasal congestion. The lot number for bnt162b2 was not provided and will be requested during follow up.  Additional information: States the 3rd dose was administered on 03Dec2021 with lot number that looks like written as EN6202 but there is also written FF2593. Caller states she began taking Losartan and does not know what date it was filled but it was on 08Dec2021 and written on it is 10Dec2021 and 06Dec2022 is when it expires. States she called the withheld information helpline and they told her to go to the store to get nasal saline spray and it helped a whole lot but the symptoms are still coming and it is withheld nasal saline spray and she sees it is 3 fluid ounces of 88 milliliters and she does not really see a lot number and then states the bottle has 006205 on it and the expiry is she guesses 20Dec2022 or that is when she bought it and it also has IAK1006 and 3122117F7 on the bottle.